Bonesupport Holding AB (publ) (STO:BONEX)

Market Cap	13.51B -42.2%
Revenue (ttm)	1.17B +30.7%
Net Income	142.15M +6.3%
EPS	0.66 -67.2%
Shares Out	66.76M
PE Ratio	95.06
Forward PE	44.51
Dividend	n/a
Ex-Dividend Date	n/a

Volume	400,179
Average Volume	312,512
Open	197.00
Previous Close	202.40
Day's Range	191.10 - 202.00
52-Week Range	165.00 - 402.00
Beta	0.39
RSI	56.10
Earnings Date	Feb 24, 2026

About Bonesupport Holding AB

Bonesupport Holding AB (publ), an orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally. The company provides CERAMENT Bone Void Filler, an injectable ceramic bone graft substitute that remodels to host bone; CERAMENT G, an injectable ceramic bone graft substitute that remodels to host bone and elutes Gentamicin during the critical first 30 days of bone healing, as well as treats and prevents bone infection; CERAMENT V, an injectable ceramic bone graft substitute t...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1999
• Employees: 143
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: BONEX

Financial Performance

In 2025, Bonesupport Holding AB's revenue was 1.17 billion, an increase of 30.70% compared to the previous year's 898.73 million. Earnings were 142.15 million, an increase of 6.28%.